T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1.
作者信息
Bhattacharyya J, Mihara K, Kitanaka A, Yanagihara K, Kubo T, Takei Y, Kimura A, Takihara Y
出版信息
Blood Cancer J. 2012 Jun;2(6):e75. doi: 10.1038/bcj.2012.21. Epub 2012 Jun 22.
Abstract
摘要
Zotero 插件